Supreme Court: Second Bail Order Must Record Changed Circumstances or Fresh Grounds  ||  SC: Severity of Injury Alone Cannot Prove Attempt to Murder Without Intent to Cause Death  ||  SC: Promissory Estoppel Cannot Be Used to Claim Unintended Benefits, Lays Down Principles  ||  Kerala High Court: No Unrestricted RTI; DPDP Act Strengthens Privacy Framework  ||  Allahabad High Court: Juvenile Offence Case Does Not Bar Govt Job In Adulthood  ||  Gauhati HC: Burden Of Proving Citizenship Stays With Proceedee and Does Not Shift At Any Stage  ||  Delhi HC: Property Disputes Between In-Laws and Daughter-In-Law are Not Exclusively For Family Court  ||  Delhi High Court: After Probate is Granted, A Will Does Not Require Fresh Proof under Section 68  ||  Ker HC: Periodic Replacement and Maintenance of Prosthetic Limb Must Be Included in Compensation  ||  Madras High Court: DNA Test Not Required For Mother to Donate Kidney to Her Son    

National Pharmaceutical Pricing Authority Notifies All Medical Devices Under Price Control - (02 Apr 2020)

LAW OF MEDICINE

National Pharmaceutical Pricing Authority has notified all medical devices sold in India as ‘drugs’ to bring the devices — such as syringes, needles, cardiac stents, a knee implant, digital thermometers, CT scan, MRIs and dialysis machines — under the purview of price control and prohibit firms from hiking their costs by more than 10% annually at a time.

Tags : NATIONAL PHARMACEUTICAL PRICING AUTHORITY   ALL MEDICAL DEVICES UNDER PRICE CONTROL  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved